Mackenzie, Isla SHawkey, Christopher JFord, IanGreenlaw, NicolaPigazzani, FilippoRogers, AmyStruthers, Allan DBegg, Alan GWei, LiAvery, Anthony JTaggar, Jaspal SWalker, AndrewDuce, Suzanne LBarr, Rebecca JDumbleton, Jennifer SRooke, Evelien DTownend, Jonathan NRitchie, Lewis DMacDonald, Thomas MALL-HEART Study Group2024-04-162024-04-162024-03-01Mackenzie, I S, Hawkey, C J, Ford, I, Greenlaw, N, Pigazzani, F, Rogers, A, Struthers, A D, Begg, A G, Wei, L, Avery, A J, Taggar, J S, Walker, A, Duce, S L, Barr, R J, Dumbleton, J S, Rooke, E D, Townend, J N, Ritchie, L D, MacDonald, T M & ALL-HEART Study Group 2024, 'Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease : the ALL-HEART RCT and economic evaluation', Health technology assessment (Winchester, England), vol. 28, no. 18. https://doi.org/10.3310/ATTM40921366-5278https://hdl.handle.net/2164/23247Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: 11/36/41) and is published in full in Health Technology Assessment; Vol. 28, No. 18. See the NIHR Funding and Awards website for further award information.862297157engSDG 3 - Good Health and Well-beingHumansMaleMiddle AgedAgedFemaleAllopurinol/therapeutic useCost-Benefit AnalysisAcute Coronary SyndromeQuality of LifeProspective StudiesUric AcidMyocardial Ischemia/drug therapyGout/drug therapyStroke/drug therapyMyocardial Infarction/drug therapyR MedicineRA0421 Public health. Hygiene. Preventive MedicineNational Institute for Health Research (NIHR)11/36/41RRA0421Journal article10.3310/ATTM4092http://www.scopus.com/inward/record.url?scp=85189277239&partnerID=8YFLogxK2818